NTAGI recommends reducing Covishield dose gap to 8-16 weeks

The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap of Covid vaccine Covishield to 8 to 16 weeks after 1st dose of vaccine in view of ongoing Omicron pandemic, said a source on Sunday.

Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose under the national vaccination drive. India’s apex body on immunisation NTAGI has recommended this in view of recent surge in the global Covid caseload.

The recommendation is expected to ramp up the administration of the second dose of Covishield to the remaining population amid rising cases in European nations and some other countries.

The government had on May 13, 2021 extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks based on the recommendations by NTAGI that provides guidance to the Union Health Ministry on the immunisation.

Medlarge

Recent Posts

70-year-old undergoes Total Knee Replacement using augmented reality technology

A 70-year-old male underwent a transformative Total Knee Replacement (TKR) procedure, utilizing augmented reality (AR)…

2 days ago

Doctors remove 16.7 kgs tumor from back of 27-year-old international patient

In an extraordinary display of medical expertise and teamwork, Fortis Memorial Research Institute, Gurugram, has…

2 days ago

CNS Tuberculosis: Experts prioritize early diagnosis, surgery technique and Brain Shunt Management

Tuberculosis remains a major health problem in India, causing approximately 220,000 deaths each year. In…

2 days ago

Total 14 Patanjali products license cancelled, SC hearing scheduled for Tuesday

The Uttarakhand government has initiated major action against Baba Ramdev in light of misleading advertisements…

5 days ago

Covishield maker AstraZeneca admits Covid vaccine can cause rare side effects

For the first time post Covid period, the Covishield vaccine maker AstraZeneca has admitted that…

5 days ago

Over 50% of patients face delay in discharge due to mediclaim process: Study

A new study from healthcare provider Pristyn Care found that 5 out of 10 patients…

5 days ago